CKMB CTnI MYO 3 In 1 Combo Rapid Test Kit In Human Whole Blood Plasma And Serum

Price	Negotiable
MOQ	1000
Delivery Time	7 Days
Brand	WWHS
Place of Origin	CN
Certification	CE
Model Number	cTnI / CK-MB / Myo
Packaging Details	Colorful Paper Box
Payment Terms	T/T
Supply Ability	30000 Kits per Week

Product Details

Product Specification

Place of Origin	CN	Packaging Details	Colorful Paper Box
Product Name	cTnI+Myo+CKMB	Model Number	cTnI / CK-MB / Myo
Supply Ability	30000 Kits per Week	Feature	High Accuracy
Certification	CE	Brand Name	WWHS
Payment Terms	T/T	Supply Capacity	2 Million a year
Type	One Step Assay	Reactivity	Human
Format	Cassette	Advantage	High Sensitivity
Price	Negotiable	Delivery Time	7 Days
Formal Name	Cardiac Troponin I / MB lsoenzyme of Creatine / Kinase	Minimum Order Quantity	1000
Manufacturer	WWHS Biotech INC	Annual Capacity	10 Million a Year

Product Description

Product Name 

Creatinekinase MB Rapid Diagnostic Kit (Immunochromatography)

Intended Use 

CK-MB is one of the most important myocardial markers, with well-established

roles in confirming acute myocardial infarction (AMI) and in monitoring

reperfusion during thrombolytic therapy following AMI.

Test Principle 

The test utilizes antibodies including a recombinant protein on the nitrocellulose

membrane with colloidal gold marked mixed CK-MB antigen as a mark tracer.

The reagent is used to detect the CK-MB in serum/plasma/whole blood

according to the principle of double antibody sandwich method and gold

immunochromatography assay. The sensitivity can reach to 5ng/ml.

Main components

Sample pad, colloidal gold marked pad, nitrocellulose membrane, absorbent

paper and PVC board.

Sample requirement

1. Collect venous blood a clean and dry container according to the standard method. Separate the serum or plasma for testing. EDTA, sodium citrate, sodium oxalate, heparin can be used as the anticoagulants

2. After collection, separate the serum and plasma as soon as possible, in order to avoid hemolysis.

3. Use fresh blood. Samples may be stored at 2-8°C for 3 days, and should be stored at -20°C for 2 years. Do not freeze and thaw the sample repeatedly. Frozen refrigerated samples should be recovered to room temperature before detection.

Storage and Expiry 

Store as packaged in the sealed pouch at 4-30°C, avoid hot and sunshine, dry

place, valid for 24 months. DO NOT FREEZE. Some protective measures should

be taken in hot summer and cold winter to avoid high temperature or

freeze-thaw.

Test Procedure 

Instructions must be read entirely before taking the test. Allow the test device controls to equilibrate to room temperature for 30 minutes (20°C-30°C) prior to testing. Do not open the inner packaging until ready, it must be used in one

hour if opened (Humidity: 20%~90%, Temp: 10°C-50°C) Strip and Cassette: Strip: 1. Take off the outer packing, put the strip onto the desk with the sample adding area of the strip up.

2. Drop 3 drops (100ul) of serum/plasma/whole blood vertically onto the sample pad of strip. If the blood is thick, add about 1 drop of (40-50μl) sample buffer onto the sample pad of strip.

3. Observe the test results immediately within 20 minutes, the result is invalid over 20 minutes.

WWHS Assay list
Cardiac
cat#.	Product Item	Specimen	Reaction Time	Measure Range	Clinical Range	Intended Use
1	cTnI	WB/Serum/Plasma	12min.	0.1-40ng/ml	<0.3ng/ml	several heart diseases including myocardial infarction and heart failure.
2	Myo	WB/Serum/Plasma	12min.	5-400ng/ml	<58ng/ml	acute myocardial infarction (AMI) in early stage.
3	CK-MB	WB/Serum/Plasma	12min.	1-200ng/ml	<5ng/ml	acute myocardial infarction (AMI) in early stage.
4	NT-proBNP	WB/Serum/Plasma	10min.	20-35000pg/ml	Under 75:0~347pg/mL, Over 75:0~449pg/mL	heart failure .
5	D-Dimer	WB/Plasma	10min.	40-10000ng/ml	<500ng/ml	disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
6	cTnI+Myo+CKMB	WB/Serum/Plasma	12min.	same with single item	same with single item	Triple marker of myocardial infarction.
7	ST2	WB/Serum/Plasma	10min.	10-400ng/ml	<35ng/ml	heart failure .
8	Lp-PLA2	WB/Serum/Plasma	10min.	10-900ng/ml	<175ng/ml	Risk evaluation of ACS and atherosclerotic ischemic stroke patients.
9	S100-β	WB/Serum/Plasma	10min.	0.05-10ng/ml	<0.2ng/ml	Cerebral infarction, cerebral injury.

CKMB CTnI MYO 3 In 1 Combo Rapid Test Kit In Human Whole Blood Plasma And Serum

Product Details

Product Specification

Product Description

You May Also Like

Get Latest Price

WWHS Biotech.Inc(exclusive marketed by Dawin)